Elite Pharmaceuticals Inc (ELTP)

[Just give me $1.50]

Wrong case.

Yes, the U.S. Supreme Court declined to hear an appeal in the case of , No. 23-1953 (Fed. Cir. 2024), effectively allowing the Federal Circuit's decision to stand.https://law.justia.com/cases/federal/appellate-courts/cafc/23-1953/23-1953-2024-12-30.html?utm_source=chatgpt.comIn this case, Purdue Pharma appealed a district court ruling that invalidated its patent claims related to an abuse-deterrent formulation of OxyContin. The district court had found that Purdue failed to establish a sufficient nexus between the commercial success of the reformulated product and the patented features. The Federal Circuit upheld this decision, and the Supreme Court's refusal to grant certiorari means that the Federal Circuit's ruling remains in effect.https://casetext.com/case/purdue-pharma-lp-v-accord-healthcare-inc?utm_source=chatgpt.com